Ridgeback Capital
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
2Deep-tech portfolio0 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Ocugen
13Co-investorsShare a portfolio company
Portfolio · 2 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Ocugen | Biotech | Public | May 7, 2020 | $126.4M |
| Day One Biopharmaceuticals | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#189
Portfolio exits#103
Raises, 12 months#88
Co-investors#144
Co-investors
- Aisling CapitalVenture capital1 shared
- Apple Tree PartnersVenture capital1 shared
- Atlas VentureVenture capital1 shared
- Boxer CapitalVenture capital1 shared
- Brookside CapitalVenture capital1 shared
- Cormorant Asset ManagementVenture capital1 shared
- Frazier Healthcare PartnersVenture capital1 shared
- LifeSci Venture PartnersVenture capital1 shared
- Longitude CapitalVenture capital1 shared
- Perceptive AdvisorsVenture capital1 shared
Sectors
- Biotech2
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.